About Culture Biosciences
Culture Biosciences is a company based in San Francisco (United States) founded in 2016. Culture Biosciences has raised $107.22 million across 6 funding rounds from investors including Verily, TPB and Synthesis Capital. The company has 35 employees as of December 31, 2020. Culture Biosciences offers products and services including Stratyx™, Console, and Nexxys™. Culture Biosciences operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter San Francisco, United States
- Employees 35 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Culture Biosciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$107.22 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
Verily
& 13 more
-
Employee Count
35
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Culture Biosciences
Culture Biosciences offers a comprehensive portfolio of products and services, including Stratyx™, Console, and Nexxys™.
Cloud-integrated mobile bioreactor for cell culture process development.
Cloud-based system for bioprocess management and data analytics.
Lab-based system for bioprocess experiments and optimization.
People of Culture Biosciences
Unlock access to complete
Funding Insights of Culture Biosciences
Culture Biosciences has successfully raised a total of $107.22M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Culture Biosciences
Culture Biosciences has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Verily, TPB and Synthesis Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund focused on SaaS and consumer sectors
|
Locked | Locked | Locked |
Investor details for Culture Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Culture Biosciences
Investment portfolio details for Culture Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Culture Biosciences
Detailed financials for Culture Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Culture Biosciences Comparisons
Peer comparison for Culture Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Culture Biosciences
Culture Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of Culture Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Culture Biosciences
Complete news archive for Culture Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Culture Biosciences
Culture Biosciences was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Culture Biosciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Chris Williams is the current CEO of Culture Biosciences.
Culture Biosciences is a funded company, having raised a total of $107.22M across 6 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Culture Biosciences is 35.
Culture Biosciences was founded in 2016 in San Francisco, United States, and operates in the biomanufacturing sector. A digital platform has been developed by the company, integrating automated bioreactors, robotic sample handling, and cloud-based data monitoring. Services offered include strain screening, media optimization, and process development to support research activities.
Culture Biosciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Culture Biosciences offers Stratyx™, Console, and Nexxys™.
Culture Biosciences has 14 investors. Key investors include Verily, TPB, Synthesis Capital, Cultivian Sandbox, and Craft Ventures.